Nightly News   |  December 19, 2014

Matters of the heart-disease drugs

March 31: Results of a clinical trial of Vytorin and one of its components, Zetia, showed that although the drugs lowered cholesterol as expected, they failed to reduce heart disease. NBC's Robert Bazell reports.

Share This:

Sorry, we do not have a transcript available for this video at this time.